These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 21889797)
21. Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia. Stams WA; den Boer ML; Beverloo HB; Kazemier KM; van Wering ER; Janka-Schaub GE; Pieters R Haematologica; 2005 Dec; 90(12):1697-9. PubMed ID: 16330447 [TBL] [Abstract][Full Text] [Related]
22. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia. Efferth T; Sauerbrey A; Steinbach D; Gebhart E; Drexler HG; Miyachi H; Chitambar CR; Becker CM; Zintl F; Humeny A Int J Oncol; 2003 Aug; 23(2):509-17. PubMed ID: 12851703 [TBL] [Abstract][Full Text] [Related]
23. IGFBP7 participates in the reciprocal interaction between acute lymphoblastic leukemia and BM stromal cells and in leukemia resistance to asparaginase. Laranjeira AB; de Vasconcellos JF; Sodek L; Spago MC; Fornazim MC; Tone LG; Brandalise SR; Nowill AE; Yunes JA Leukemia; 2012 May; 26(5):1001-11. PubMed ID: 22005787 [TBL] [Abstract][Full Text] [Related]
24. Effect of Cx43 gene-modified leukemic bone marrow stromal cells on the regulation of Jurkat cell line in vitro. Zhang X; Liu Y; Si YJ; Chen XH; Li ZJ; Gao L; Gao L; Zhang C Leuk Res; 2012 Feb; 36(2):198-204. PubMed ID: 22030334 [TBL] [Abstract][Full Text] [Related]
25. [In vitro drug resistance as independent prognostic factor in the study COALL-O5-92 Treatment of childhood acute lymphoblastic leukemia; two-tiered classification of treatments based on accepted risk criteria and drug sensitivity profiles in study COALL-06-97]. Janka-Schaub GE; Harms DO; den Boer ML; Veerman AJ; Pieters R Klin Padiatr; 1999; 211(4):233-8. PubMed ID: 10472556 [TBL] [Abstract][Full Text] [Related]
26. ZAP-70 is highly expressed in most cases of childhood pre-B cell acute lymphoblastic leukemia. Wandroo F; Bell A; Darbyshire P; Pratt G; Stankovic T; Gordon J; Lawson S; Moss P Int J Lab Hematol; 2008 Apr; 30(2):149-57. PubMed ID: 18333847 [TBL] [Abstract][Full Text] [Related]
28. Highly aggressive lymphomas in adults. Sweetenham JW Hematol Oncol Clin North Am; 2008 Oct; 22(5):965-78, ix. PubMed ID: 18954746 [TBL] [Abstract][Full Text] [Related]
29. Somatic mutation of IL7R exon 6 in acute leukemias and solid cancers. Kim MS; Chung NG; Kim MS; Yoo NJ; Lee SH Hum Pathol; 2013 Apr; 44(4):551-5. PubMed ID: 23069254 [TBL] [Abstract][Full Text] [Related]
30. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure. Beesley AH; Cummings AJ; Freitas JR; Hoffmann K; Firth MJ; Ford J; de Klerk NH; Kees UR Br J Haematol; 2005 Nov; 131(4):447-56. PubMed ID: 16281934 [TBL] [Abstract][Full Text] [Related]
31. Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia. Boag JM; Beesley AH; Firth MJ; Freitas JR; Ford J; Hoffmann K; Cummings AJ; de Klerk NH; Kees UR Leukemia; 2006 Oct; 20(10):1731-7. PubMed ID: 17041637 [TBL] [Abstract][Full Text] [Related]
32. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance. Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514 [TBL] [Abstract][Full Text] [Related]
33. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia. Styczynski J; Pieters R; Huismans DR; Schuurhuis GJ; Wysocki M; Veerman AJ Br J Haematol; 2000 Sep; 110(4):813-8. PubMed ID: 11054062 [TBL] [Abstract][Full Text] [Related]
34. High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse. Shalapour S; Hof J; Kirschner-Schwabe R; Bastian L; Eckert C; Prada J; Henze G; von Stackelberg A; Seeger K Haematologica; 2011 Nov; 96(11):1627-35. PubMed ID: 21828124 [TBL] [Abstract][Full Text] [Related]
35. CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment. Juarez J; Dela Pena A; Baraz R; Hewson J; Khoo M; Cisterne A; Fricker S; Fujii N; Bradstock KF; Bendall LJ Leukemia; 2007 Jun; 21(6):1249-57. PubMed ID: 17410186 [TBL] [Abstract][Full Text] [Related]
36. The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia. de Bock CE; Ardjmand A; Molloy TJ; Bone SM; Johnstone D; Campbell DM; Shipman KL; Yeadon TM; Holst J; Spanevello MD; Nelmes G; Catchpoole DR; Lincz LF; Boyd AW; Burns GF; Thorne RF Leukemia; 2012 May; 26(5):918-26. PubMed ID: 22116550 [TBL] [Abstract][Full Text] [Related]
37. Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs. Campana D; Manabe A; Evans WE Leukemia; 1993 Mar; 7(3):482-8. PubMed ID: 7680404 [TBL] [Abstract][Full Text] [Related]